Cheri Gravalos

Director of Alliance, Management

Cheri Gravalos brings over 20 years of experience in business development and operations in life sciences, medical device, platform technologies, and clinical services. Mrs. Gravalos joined COI in 2014 and currently serves as Director of Alliance Management.

Prior to joining COI Mrs. Gravalos was Senior Advisor, Business Transformation, Life Sciences for Cisco System where she helped build transformative innovation for the life science industry. Additionally, she established a business development consulting practice, called C3, which facilitated small- and mid-cap companies with partnering, strategy, business planning, marketing, sales, startup activities and fundraising.

Mrs. Gravalos holds a M.B.A. in Business Management and Finance, and B.S. in Information Systems from San Diego State University-California State University.

in the news

  • Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 billion

    read more
  • COI Pharmaceuticals Announces Acquisition of Calporta by Merck

    read more
  • Avalon Ventures and COI Pharmaceuticals Announce Acquisition of Sitari Pharmaceuticals by GSK

    read more